<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <title>ScholarWorks Community:</title>
  <link rel="alternate" href="https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/358" />
  <subtitle />
  <id>https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/358</id>
  <updated>2026-04-04T16:13:00Z</updated>
  <dc:date>2026-04-04T16:13:00Z</dc:date>
  <entry>
    <title>Case Report: Single-port laparoscopic total gastrectomy for gastric cancer in patient with situs inversus totalis</title>
    <link rel="alternate" href="https://scholarworks.korea.ac.kr/kumedicine/handle/2021.sw.kumedicine/62384" />
    <author>
      <name>Lee, In Young</name>
    </author>
    <author>
      <name>Lee, Danbi</name>
    </author>
    <author>
      <name>Lee, Chang Min</name>
    </author>
    <id>https://scholarworks.korea.ac.kr/kumedicine/handle/2021.sw.kumedicine/62384</id>
    <updated>2025-09-08T09:49:24Z</updated>
    <published>2023-01-01T00:00:00Z</published>
    <summary type="text">Title: Case Report: Single-port laparoscopic total gastrectomy for gastric cancer in patient with situs inversus totalis
Authors: Lee, In Young; Lee, Danbi; Lee, Chang Min
Abstract: Situs inversus totalis (SIT) is a rare anatomical condition, where all the viscera appear in its reverse position. Although minimally invasive surgery has evolved to achieve totally laparoscopic gastrectomy for gastric cancer patients with SIT, it is difficult to perform lymphadenectomy in such a transposed anatomical condition. Recently, we performed a single-port laparoscopic total gastrectomy (SPTG) for gastric cancer in a patient with SIT. No postoperative complications or dietary problems were observed. Based on this experience, we are to design a safe strategy to perform D2 lymphadenectomy during SPTG in patients with SIT.</summary>
    <dc:date>2023-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Can We Reboot the Role of Intraperitoneal Chemotherapy in the Treatment for Gastric Cancer with Peritoneal Carcinomatosis?: A Retrospective Cohort Study Regarding Minimally Invasive Surgery Conjoined with Intraperitoneal plus Systemic Chemotherapy</title>
    <link rel="alternate" href="https://scholarworks.korea.ac.kr/kumedicine/handle/2021.sw.kumedicine/60933" />
    <author>
      <name>Kim, Sungho</name>
    </author>
    <author>
      <name>Lee, Chang-Min</name>
    </author>
    <author>
      <name>Lee, Danbi</name>
    </author>
    <author>
      <name>Kim, Jong-Han</name>
    </author>
    <author>
      <name>Park, Sungsoo</name>
    </author>
    <author>
      <name>Park, Seong-Heum</name>
    </author>
    <id>https://scholarworks.korea.ac.kr/kumedicine/handle/2021.sw.kumedicine/60933</id>
    <updated>2025-06-25T00:31:01Z</updated>
    <published>2022-05-01T00:00:00Z</published>
    <summary type="text">Title: Can We Reboot the Role of Intraperitoneal Chemotherapy in the Treatment for Gastric Cancer with Peritoneal Carcinomatosis?: A Retrospective Cohort Study Regarding Minimally Invasive Surgery Conjoined with Intraperitoneal plus Systemic Chemotherapy
Authors: Kim, Sungho; Lee, Chang-Min; Lee, Danbi; Kim, Jong-Han; Park, Sungsoo; Park, Seong-Heum
Abstract: Background: Peritoneal carcinomatosis (PC) is the most common form of metastasis in gastric cancer (GC) and is related with a poor prognosis. Several treatment modalities including systemic chemotherapy and intraperitoneal chemotherapy have been studied and adopted in treatment of GC patients with PC. Nevertheless, few studies have reported the comparison of the oncologic outcomes between minimally invasive surgery (MIS) with intraperitoneal (IP) chemotherapy and conventional chemotherapy for GC with PC. 

Methods: We retrospectively reviewed the clinical records of 74 patients who had been diagnosed as GC with PC via either intra-abdominal exploration or abdominopelvic computed tomography between January 2011 and April 2021. After performing propensity score-matching for this retrospective data, we compared the outcomes of 26 patients who underwent MIS followed by IP combined systemic chemotherapy (MIS-IP group) and 26 patients who underwent systemic chemotherapy only (SC-only group). 

Results: The 2-year progression free survival rate of the MIS-IP group was significantly higher than the SC-only groups (36.4% and 10.5%, respectively; p = 0.010). In multivariate analysis to detect relevant factors on PFS, IP chemotherapy (HR 0.213; p &amp;lt; 0.001), Eastern Cooperative Oncology Group performance status (HR 3.689; p = 0.002), and the amount of ascites (p = 0.011) were significant prognostic factors. 

Conclusions: This study demonstrated the therapeutic potential of MIS conjoined IP plus systemic chemotherapy for GC patients with PC. MIS conjoined by IP plus systemic chemotherapy can be adopted as a treatment option to reboot the role of IP chemotherapy in GC patients with PC.</summary>
    <dc:date>2022-05-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Which Patients With Newly Diagnosed Breast Cancer Benefit From Preoperative Magnetic Resonance Imaging?</title>
    <link rel="alternate" href="https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/54703" />
    <author>
      <name>Lee, Hyun Jeong</name>
    </author>
    <author>
      <name>Kim, Woo Young</name>
    </author>
    <author>
      <name>Lee, Jae Bok</name>
    </author>
    <author>
      <name>Ha, Kee Soo</name>
    </author>
    <author>
      <name>Chang, Young Woo</name>
    </author>
    <author>
      <name>Lee, Hye Yoon</name>
    </author>
    <author>
      <name>Jung, Seung Pil</name>
    </author>
    <author>
      <name>Lee, Yeonjoo</name>
    </author>
    <author>
      <name>Woo, Ok Hee</name>
    </author>
    <author>
      <name>Woo, Sang Uk</name>
    </author>
    <author>
      <name>Son, Gil Soo</name>
    </author>
    <id>https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/54703</id>
    <updated>2025-04-09T06:30:10Z</updated>
    <published>2021-10-01T00:00:00Z</published>
    <summary type="text">Title: Which Patients With Newly Diagnosed Breast Cancer Benefit From Preoperative Magnetic Resonance Imaging?
Authors: Lee, Hyun Jeong; Kim, Woo Young; Lee, Jae Bok; Ha, Kee Soo; Chang, Young Woo; Lee, Hye Yoon; Jung, Seung Pil; Lee, Yeonjoo; Woo, Ok Hee; Woo, Sang Uk; Son, Gil Soo
Abstract: Objective: The aim of this study was to identify the effectiveness and selective applications of preoperative magnetic resonance imaging (MRI) by investigating clinicopathologic factors of the index tumor with or without false lesions on MRI. Summary of background data: Preoperative MRI is commonly performed in patients with newly diagnosed breast cancer, but its clinical significance is unclear. Methods: A total of 103 breast cancer patients who had undergone MRI or ultrasound followed by mastectomy were included in this retrospective investigation of pathologic, clinical, and imaging findings. Results: MRI showed 29 false-positive lesions in 57 patients, 5 false-negative lesions in 5 patients, and 69 true-positive lesions in 103 patients. More false lesions on MRI were found in patients with more lesions on ultrasound, small-sized index tumors on ultrasound, or early-stage cancer. The sensitivity of MRI and ultrasound were 96.5% and 92.3% (P = 0.119), respectively, and the positive predictive value of them were 71.5% and 72.5% (P = 0.828), respectively. Conclusions: Preoperative MRI is more useful in patients with newly diagnosed breast cancer who have large-sized or more advanced cancers or fewer lesions on ultrasound.</summary>
    <dc:date>2021-10-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Validity and reliability of a home-based, guardian-conducted video voiding test for voiding evaluation after hypospadias surgery</title>
    <link rel="alternate" href="https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/49312" />
    <author>
      <name>Han, Jae Hyeon</name>
    </author>
    <author>
      <name>Lee, Jang Hui</name>
    </author>
    <author>
      <name>Jun, Jaebeom</name>
    </author>
    <author>
      <name>Park, Min Uk</name>
    </author>
    <author>
      <name>Lee, Je Seong</name>
    </author>
    <author>
      <name>Park, Sungchan</name>
    </author>
    <author>
      <name>Song, Sang Hoon</name>
    </author>
    <author>
      <name>Kim, Kun Suk</name>
    </author>
    <id>https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/49312</id>
    <updated>2024-09-09T09:01:56Z</updated>
    <published>2020-07-01T00:00:00Z</published>
    <summary type="text">Title: Validity and reliability of a home-based, guardian-conducted video voiding test for voiding evaluation after hypospadias surgery
Authors: Han, Jae Hyeon; Lee, Jang Hui; Jun, Jaebeom; Park, Min Uk; Lee, Je Seong; Park, Sungchan; Song, Sang Hoon; Kim, Kun Suk
Abstract: Purpose: To investigate the validity and reliability of a home-based, guardian-conducted video voiding test for assessing postoperative voiding function after hypospadias surgery. Materials and Methods: In a single center, patients who had undergone urethroplasty by a single surgeon and postoperative uroflowmetry and video voiding tests conducted between 2008 and 2016 were retrospectively reviewed. Urinary stream was categorized into five grades by three pediatric urologists in a blinded manner. The primary outcome was statistical correlation across raters as measured by Spearman correlation coefficient to validate the interpretation of the video voiding test. The secondary outcome was the reliability of the voiding video test compared with maximum urinary flow rate assessed by uroflowmetry. Results: Thirty-one patients with hypospadias were enrolled. The patients&amp;apos; average ages were 12.3 +/- 3.2 months (range, 8-21 months) and 42.8 +/- 3.9 months (range, 35-48 months) at the time of surgery and voiding video tests, respectively. Hypospadias was anterior, penile, and proximal in 1 (3.2%), 18 (58.1%), and 12 (38.7%) patients, respectively. The number of patients with each voiding stream grade was as follows: very poor, 4; poor, 4; fair, 13; good, 4; and very good, 6. All intraclass correlation coefficients of the stream grade among the three observers were &amp;gt;0.95. Correlation between the maximum flow rate obtained by use of conventional uroflowmetry and the video voiding stream grade was validated (rho 0.778, p&amp;lt;0.001). Conclusions: The home-based guardian-conducted video voiding test is easy to perform and the present results demonstrate its validity and reliability for assessing patients&amp;apos; post-urethroplasty voiding pattern.</summary>
    <dc:date>2020-07-01T00:00:00Z</dc:date>
  </entry>
</feed>

